Target 2035 Fellow (Postdoctoral Researcher – Community Benchmarking & Critical Assessment)

Supervisor(s): Position 1: Benjamin Sanchez-Lengeling (University of Toronto), Pablo Meyer (IBM Research) and Gustavo Stolovitzky (NYU Langone) | Position 2:  John Moult (University of Maryland) and Matthieu Schapira (SGC)

Program: Mitacs Accelerate – Target 2035 Fellows

Location: Toronto, Canada

13.02.2026

Partnering to accelerate early drug discovery in Australia

by: SGC

GRIFFITH-February 17, 2026 - Compounds Australia (Griffith University), Australia’s national compound management facility, and the  Structural Genomics Consortium (SGC) are excited to announce a new partnership to enable access to high-quality chemical probes to accelerate early drug discovery research. Through this partnership, the SGC’s Donated Chemical Probes (DCP) library is now part of the open access compound collection of Compounds Australia. 

10.02.2026

New Open Science Project Funded to Accelerate Therapeutic Discovery for Spinal Bulbar Muscular Atrophy

by: SGC

Toronto, ON, Canada — Agora Open Science Trust, in collaboration with the Structural Genomics Consortium (SGC) and an international team of academic researchers, is pleased to announce the launch of a new one-year research project funded by Kennedy’s Disease Association (KDA). This new grant seeks to accelerate the development of targeted therapeutic strategies for Spinal Bulbar Muscular Atrophy (SBMA), a rare neuromuscular disorder with no drugs to slow or halt disease.